Sadia Munir

Sadia Munir

Higher Degree by Research Candidate

School of Biomedicine

Faculty of Health and Medical Sciences

Dose limiting toxicities of anti-cancer drugs associated with their systemic distribution after administration are a major limitation in treating many cancers including myeloma. During my PhD candidature, I am developing and investigating novel approaches, including state-of-the-art nanoparticle system and novel vascular-modulating agents to selectively increase the delivery of anti-myeloma drugs to the site of tumour to reduce their side-effects.

Title: development ans assessment of novel drug delivery stratigies to treat multiple myeloma


Connect With Me
External Profiles